• Postmortem-derived iPSC models in substance use disorders research
  Published on 2023-08-14
  2 years ago
• Electrophysiological correlates of attention in the locus coeruleus–prelimbic cortex circuit during the rodent continuous performance test
  Published on 2023-08-10
  2 years ago
• Transcranial focused ultrasound (tFUS): a promising noninvasive deep brain stimulation approach for pain
  Published on 2023-08-10
  2 years ago
• Moving beyond descriptive nosology: an argument for negative valence systems disorder
  Published on 2023-08-09
  2 years ago
• Microbes and mental health: translating preclinical findings to the clinic
  Published on 2023-08-08
  2 years ago
• Repurposing anti-inflammatory medications for alcohol and substance use disorders
  Published on 2023-08-07
  2 years ago
• High-intensity sweet taste as a predictor of subjective alcohol responses to the ascending limb of an intravenous alcohol prime: an fMRI study
  Published on 2023-08-07
  2 years ago

« Previous 1 … 66 67 68 69 70 … 143 Next »

• Isoginkgetin treatment attenuated lipopolysaccharide-induced monoamine neurotransmitter deficiency and depression-like behaviors through downregulating p38/NF-κB signaling pathway and suppressing microglia-induced apoptosis
  Published on 2021-07-20
  4 years ago
• Subjective executive function deficits in hazardous alcohol drinkers
  Published on 2021-07-19
  4 years ago
• The impacts of caffeine administration, expectancies, and related stimuli on coffee craving, withdrawal, and self-administration
  Published on 2021-07-19
  4 years ago
• GABAergic modulation of performance in response inhibition and interference control tasks
  Published on 2021-07-19
  4 years ago
• High dose antipsychotic polypharmacy and dopamine partial agonists – time to rethink guidelines?
  Published on 2021-07-14
  4 years ago
• Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis
  Published on 2021-07-09
  4 years ago
• Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium
  Published on 2021-07-09
  4 years ago

« Previous 1 … 66 67 68 69 70 … 124 Next »

• Precision psychiatry: The complexity of personalizing antipsychotic dosing
  Published on 2022-03-19
  3 years ago
• Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: Molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challenges
  Published on 2022-02-28
  3 years ago
• Are personality disorders in bipolar patients more frequent in the US than Europe?
  Published on 2022-02-26
  3 years ago
• Toward the “helioscope” hypothesis of psychedelic therapy
  Published on 2022-02-26
  3 years ago
• Is treatment-resistant depression really resistant?
  Published on 2022-02-25
  3 years ago
• The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
  Published on 2022-02-24
  3 years ago
• Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?
  Published on 2022-02-24
  3 years ago

« Previous 1 … 66 67 68 69 70 … 145 Next »